4//SEC Filing
Van Naarden Jacob 4
Accession 0000059478-25-000030
CIK 0000059478other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:26 PM ET
Size
9.8 KB
Accession
0000059478-25-000030
Insider Transaction Report
Form 4
Van Naarden Jacob
EVP & Pres., Lilly Oncology
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-02-01−3,023→ 0 totalFrom: 2025-02-01Exp: 2025-02-01→ Common Stock (3,023 underlying) - Exercise/Conversion
Common Stock
2025-02-01+3,023→ 14,868 total - Tax Payment
Common Stock
2025-02-01$811.08/sh−1,409.839$1,143,492→ 13,458.161 total
Holdings
- 4,342(indirect: By Trust)
Common Stock
- 4,302(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Documents
Issuer
ELI LILLY & Co
CIK 0000059478
Entity typeother
Related Parties
1- filerCIK 0001661254
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:26 PM ET
- Size
- 9.8 KB